Main
>
RHEUMATOLOGY>RHEUMATOID ARTHRITIS
>
Treatment
>
RituxiMAb (Approved)
>
Co.: USA. B (C20 MAb/Patents)
>
Sales Value 2002: US$ 1.48 Billion
Sales Value 2002: US$ 1.48 Billion's products
This section has no products